Back
China SXT Pharmaceuticals 10K Form
Sell
32
SXTC
China SXT Pharmaceuticals
Last Price:
0.62
Seasonality Move:
-33.16%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive SXTC News And Ratings
See the #1 stock for the next 7 days that we like better than SXTC
SXTC Financial Statistics
Sales & Book Value
| Annual Sales: | $1.93M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 0 |
| Annual Sales: | $6.28 |
| Price / Book: | 0.15 |
Profitability
| EPS (TTM): | -16.36570 |
|---|---|
| Net Income (TTM): | $-3.1M |
| Gross Margin: | $553.97K |
| Return on Equity: | -27.59% |
| Return on Assets: | -13.82% |
China SXT Pharmaceuticals Earnings Forecast
Key China SXT Pharmaceuticals Financial Ratios
- The Gross Profit Margin over the past 8 years for SXTC is 28.73%.
- The Selling, General & Administrative Expenses for SXTC have been equal to 159.15% of Gross Profit Margin.
- The Interest Expense is -17.57% of Operating Income.
- The Net Earning history of SXTC is -160.67% of Total Revenues.
- Per Share Earnings over the last 8 years have been positive in 5 years.
China SXT Pharmaceuticals Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | SXTC |
| CUSIP: | G2161P |
| Website: | sxtchina.com |
Debt
| Debt-to-Equity Ratio: | 0.17 |
|---|---|
| Current Ratio: | 1.6 |
| Quick Ratio: | 1.51 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 0 |
SXTC Technical Analysis vs Fundamental Analysis
Sell
32
China SXT Pharmaceuticals (SXTC)
is a Sell
Is China SXT Pharmaceuticals a Buy or a Sell?
-
China SXT Pharmaceuticals stock is rated a Sell
The current China SXT Pharmaceuticals [SXTC] share price is $0.62. The Score for SXTC is 32, which is 36% below its historic median score of 50, and infers higher risk than normal.